Events|

SHL Medical to speak and exhibit at the PDA Universe Conference 2024 in Phoenix

Shl Medical To Speak And Exhibit At The Pda Universe Conference 2024 In Phoenix
Join SHL at Booth #601 to discover our latest innovations and engage with our experts

SHL Medical is set to exhibit at Booth #601 at the 2024 Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference on October 22-23 in Phoenix, Arizona, USA.

This year, SHL Medical representatives are set to lead the conversation and provide in-depth coverage on key topics, including large volume injections, drug delivery platforms, incremental innovations, as well as digital health and actionable data. Our key highlights include two podium presentations, one on large-volume subcutaneous autoinjections (in collaboration with SCHOTT Pharma), and the other on the topic of the sustainability of large-volume at-home versus in-clinic infusions . Make sure to catch our presentations, posters, and panel discussion session to explore the latest breakthroughs in drug delivery.

In addition, we are excited to announce the debut of Elexy™—our versatile, electromechanical autoinjector, equipped with a reusable power unit and adaptive technology to enable a wide range of injection profiles. Visit our Booth #601 for a personal demo and attend our Tech Talk to find out how Elexy is poised to redefine the self-injection space.

We look forward to sharing insights with you on our comprehensive product portfolio, including our market-proven modular platform Molly® autoinjector, our large-volume Maggie® autoinjector with the Needle Isolation Technology (NIT®), and our Molly Connected Cap autoinjector add-on. Don’t miss the opportunity to get hands-on experience with our devices and interact with our representatives at our booth to learn more about SHL’s vertically integrated services, global expansion journey, sustainability strategies, and more.

To secure your spot at the event, register via the link below:

 

Meet our speakers!

Panel discussion

Title Presenter Time
Drug Delivery Platforms – Compare and Contrast Device and Pharma Perspectives: Device Manufacturer Perspective

Bart Burgess

Global Head of Portfolio Strategy and Customer Solutions, SHL Medical

October 23

8:00 AM MST | Session P3

Podium presentations

Title Presenter Time
A Summative Report on Exploratory Studies and Collaborative Developmental Work Toward Understanding Large Volume Subcutaneous Autoinjections

Gary Calderwood

Senior Product Manager, SHL Medical

October 22

2:20 PM MST | Track B1

Robert Lindner, PhD

Global Product Manager of Bulk and Sterile Cartridges, SCHOTT Pharma
Hidden in Plain Sight? Stored Waste with Large Volume Subcutaneous Infusions and Sustainability Implications

Ralph Howald, MSc, MBA

Chief Technology Officer, SHL Medical

October 23

10:15 AM MST | Track C3

Madeleine Anderson

Insights Manager, Matchstick

Podium presentations

Title Presenter Time
Incremental innovation to Significantly Expand Design Spaces of Injectables: A Case Study on Expanding High Viscosity Performance Through Incremental Platform Modifications

Lucy Lee, MSc

Associate Director of Product Management, SHL Medical

October 22-23

Maëlle Douaire, PhD

R&D Segment Lead for Biologics PFS, Becton, Dickinson and Company
Understanding Patient Adherence and Creating Actionable Insights from Connected Devices and Software

Chelsea Williams, MPH

Digital Health Manager, SHL Medical

October 22-23

Joe Keenan, MSc, MBA

Senior Director of Business Development North America

Tech talk

Title Presenter Time
SHL Medical’s Elexy™: Expanding True Autoinjector Versatility for the Development of Combination Products

Vince Masciopinto

Customer Solutions Director, SHL Medical

October 22

10:10 AM MST

Where   : Phoenix Convention Center – South Building, Phoenix, Arizona, USA | Booth #601

When    : October 22-23

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News